Company Overview - ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma treatments, offering allergy immunotherapy and related products and services [2] - The company is headquartered in Hørsholm, Denmark, and employs approximately 2,800 people worldwide [2] Financial Calendar - The financial calendar for ALK includes key dates such as: - 23 January 2026: Silent period begins - 20 February 2026: Annual report for 2025 is scheduled for release - 16 March 2026 at 4:00 p.m.: Annual General Meeting [4] - Additional reporting dates include: - 5 May 2026: Three-month interim report (Q1) for 2026 - 20 August 2026: Six-month interim report (Q2) for 2026 - 18 November 2026: Nine-month interim report (Q3) for 2026 [5] AGM Participation - Written requests for specific business transactions to be included in the AGM agenda must be received by the company by 30 January 2026 [1]

Company announcement no. 31/2025 Columbus Financial Calendar for 2026: Annual Report 202512 March 2026Annual General Meeting23 April 2026Interim Report Q1 20267 May 2026Interim Report Q2 202620 August 2026Interim Report Q3 20265 November 2026 After publication of financial statements the Company will conduct an investor presentation via a conference call and webcast. For details regarding the conference calls, please see the Company’s website: https://ir.columbusglobal.com/calendar-and-events Annual Gener ...